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OBJECTIVES Our previous study has indicated that serum chemokine
ligand 17 (CCL17) levels are associated with coronary artery disease
(CAD) and atherosclerosis severity. This study is to further determine
the relationship among genetic variants in ccl17, serum CCL17 levels,
and CAD in Chinese Han population.
METHODS Nine hundred and forty seven patients (153 patients with
non-CAD and 794 patients with CAD) presenting to our center for
coronary angiography were recruited consecutively. Five tag single-
nucleotide polymorphisms (SNPs) including rs223895, rs4784805,
rs9302690, rs223899, and rs223828 were identiﬁed using HapMap
Project data and determined by TaqMan genotyping. Serum CCL17
levels were determined by enzyme-linked immunosorbent assay.
With an additive genetic model, both linear and logistic regression
models (adjusted for covariates of age, gender, body mass index,
hypertension, diabetes, lipid proﬁle, smoking status, and family his-
tory of CAD) were used to investigate the relationship among tag
SNPs, serum CCL17 levels, and CAD.
RESULTS Minor allele T at rs223828 was signiﬁcantly associated with
higher serum CCL 17 levels (b ¼ 18.92 per effect allele of SNP, 95%
conﬁdence interval 2.16w35.68, p ¼0.027). Besides, minor allele T at
rs223328 was also associated with increased risk of CAD (Odd ratio ¼
2.39 per effect allele of SNP, 95% conﬁdence interval 1.43w4.02,
p ¼0.001). There is no signiﬁcant association among other SNPs,
serum CCL17 levels, and CAD risk.
CONCLUSIONS rs223828 in ccl17 is linked to both serum CCL 17 levels
and risk of CAD in Chinese Han population.
GW26-e5419
Does heart failure cause ischemia?
Thach Nguyen,1,4 Hau Van Tran,2 Phillip Tran,3
Tai Truyen Thien Tan Tri,4 Gianluca Rigatelli5
1St Mary Medical Center, Hobart IN; 2New York Institute of Technology,
College of Osteopathic Medicine, Old Westbury NY; 3Internal Medicine
Residency Program Mercy Medical Center- Des Moines IA USA; 4Tan
Tao University School of Medicine Tan Duc Ecity, Duc hoa - Long An
Vietnam; 5Cardiovascular Diagnosis and Endoluminal Interventions
Unit, Rovigo General Hospital, Rovigo, Italy
OBJECTIVES New onset of heart failure (HF) is indication for inves-
tigation of signifcant coronary artery disease (CAD), including stress
test or coronary angiogram. In many cases, the angiogram results
showed mild CAD with mild to moderate left ventricular dysfunction
and the management was suggested to continue medical treatment
without indication for percutaneous coronary interventions (PCI) or
open heart surgery (CABG). In these cases, did CAD cause HF or did HF
cause ischemic changes on EKG and chest pain? Did the elevation of
the left ventricular (LV) end diastolic pressure (representing the sys-
tolic and diastolic dysfunction) cause any EKG changes suggestive
ischemia?
METHODS 20 patients were consecutively selected with the following
criteria: (1) history of new onset of HF on presentation to the emergency
room (shortness of breath, rales in lungs, treated with intravenous di-
uretics) (2) having chest pain in the index admission, (3) EKG changes of
ischemia (only ST depression or T wave inversion) (no ST segment
elevation) AND (4) negative coronary angiogram not requiring PCI or
CABG. All patients underwent coronary angiogram and LV angiogram.
Electrocardiogram (EKG) changes were classiﬁed as type 1 (mild
nonspeciﬁc ST T changes) type 2 (ST depression (>1mm) and deep
symmetrical T wave inversion (type 3). Ejection fraction (EF), aortic
systolic (AOS) and diastolic pressure (AOP) were recorded. The key
formula is the coronary perfusion pressure (CPP) ¼ AOD-LVEDP. How
was the CPP in patients with HF and no severe CAD?RESULTS The results showed all patients had high LVEDP. However,
the AO Diastolic (AOD) pressure was lower during the index events. In
patient with elevated LVEDP and signiﬁcant low AOD, with
CPP<20 mmHg, the EKG changes with deep T waves inversion (type 3)
were very obvious even the coronary angiograms were negative. If the
CPP was between 20-30 mmHg, the EKG changes were more of type 2
of mild ST depression. If the CPP> 30 mmHg, there were normal EKG
or only type 1 non speciﬁc STT changes. It is clearly that CPP<
30 mmHg caused ischemia on patients and in EKG. Once the elevated
LVEDP was treated to a lower level or when the OAD pressure
improved (no more hypotension), the EKG changes disappeared (from
type 3 to type 1) and the chest pain improved.
CONCLUSIONS In patients presenting with HF associated with chest
pain and EKG changes suggested of ischemia, a combination of low
aortic diastolic pressure (AOD) and elevated LVEDP was associated
with ischemia in patients with no signiﬁcant lesions in coronary ar-
teries. The reason is that the coronary perfusion pressure (CPP) is the
difference between AOD and LVEDP and the CPP could be decreased
and cause ischemia (due to low perfusion pressure) even the coronary
arteries are patent. These results are important to understand that LV
dysfunction could cause ischemia in selected patients and could be
the cause of death in patient with elevated LVEDP (e.g.CAD with LV
dysfunction or aortic stenosis) undergoing PCI.
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OBJECTIVES Early diagnosis is critical for the management of acute
myocardial infarction (AMI). Beside ECG, circulating cardiac bio-
markers are routinely used for the early detecting myocardial necrosis
including CK, CK-MB, troponins (Tns) or hsTn, and myoglobin. These
traditional biomarkers have not been helpful for diagnosing AMI until
3-6 after symptoms, when their blood levels rise and some have poor
cardiac-speciﬁcity. Recent studies demonstrated macrophage migra-
tion inhibitory factor (MIF) rose in early MI, and, unlike hsTn, pre-
dicted infarct size. It is unknown whether ischemia without infarction
is also associated with MIF. In this study, MIF and hsTn were exam-
ined in patients experiencing myocardial ischemia. The possibility of
MIF released from ischemic skeletal muscle was also examined in
patients with peripheral artery obstructive disease (PAOD).
METHODS There were 2 patient cohorts. The ﬁrst (n¼83) comprised
chest-pain patients referred for possible myocardial ischemia by
either stress echocardiography or nuclear images after exercise. The
second cohort comprised patients with known PAOD (n¼10) who un-
derwent a 6 minutes walk test (6MWT) and developed claudication. In
both groups blood samples were obtained before (baseline) and at 5
and 15 mins after excise. All blood was stored at -80C prior to analysis
for MIF (ng/ml), hsTn (mg/l) and hsCRP (mg/L). In the ﬁrst cohort
subjects with exercise induced onset of symptoms and regional wall
motion abnormality or reversible perfusion were classiﬁed as positive
whilst those without such changes and without ECG changes were
classiﬁed as negative. In addition, protein and mRNA expressions of
MIF in mice hearts and leg muscles (n¼5 for each) were also studied.
RESULTS In the chest-pain cohort there were 19 positive (6310.6
years old) and 64 negative (62.510.6 years). No differences were in
baseline hsCRP (2.72.0 and 4.312.7) or MIF (59.933.4 and
52.521.5) between positive and negative groups. No changes were
with exercise for hsTn or hsCRP in either group. However, in the
positive group, the 5 and 15 min MIF difference from baseline were
16.55.5 and 7.74.5 respectively while in the negative group they
were 0.372.33 and -4.82.33. Both changes of MIF at 5 and 15 min
from the baseline in positive group are signiﬁcantly different (p<0.01,
P<0.05 respectively) comparing with them in negative group. In
contrast circulatory MIF levels in PAOD patient showed no statistically
changes at 5min (63.455.6) and 15 min (41.414.7) after 6MWT
compared with baseline (45.719.9). The MIF protein and mRNA were
3.05 0.38 vs. 1.000.53 and 29.615.3 vs. 1.40.4 in mice hearts and
leg muscles respectively which are signiﬁcant different between two
tissues (p<0.001).
CONCLUSIONS Plasma MIF elevation responding to myocardial
ischemia indicates different mechanisms of release between MIF and
